Ongoing & Upcoming

Research Projects

Upskill TB

Upskill TB is a free, innovative global online learning platform designed to strengthen the response to Drug-Resistant Tuberculosis (DR-TB). The platform offers expert-led modules focused on the BPaL/M regimen, supporting the development of both knowledge and practical competencies in DR-TB care, patient management, and health system strengthening.

Ad5-105K Inhaled TB Vax Phase 1

A Phase 1 randomized, double-blind, placebo-controlled and dose-escalation study to evaluate the safety and immunogenicity of a viral vector-based Tuberculosis (TB) vaccine Ad5-105K against TB Disease in adults aged 18 to 49 years.

ONWARDS

ONWARDS Aims to support the national program by accelerating the implementation of the BPaL/M regimen as an alternative treatment for drug‑resistant TB patients in Indonesia, by aligning implementation at provincial and district/city levels and strengthening the capacity of health workers and stakeholder support.

DriveDx4TB
TOO

Evaluating next generation LAM assays and molecular diagnostics [near Point of Care (POC) and low complexity nucleic acid amplification tests (NAATs)] for the diagnosis of TB among people with presumptive TB: a prospective multicentre diagnostic accuracy study.

PREATTRI

Pretreatment Attrition in People with Drug-Resistant Tuberculosis

PRIMA-4TB

The Usage of Rifapentine, Isoniazid, Pyrazinamide, and Moxifloxacin Combination for 4 months for Drug-Sensitive Tuberculosis Patients in Indonesia

BGSI

Human Genomic Analysis and Mycobacterium Tuberculosis in Cases of Drug-Sensitive and Drug-Resistant Pulmonary TB in Indonesia

Tongue Swab

Evaluating next generation LAM assays and molecular diagnostics (near POC and low complexity NAATs) for the diagnosis of TB among people with presumptive TB: a prospective multicentre diagnostic accuracy study

Vit C Zinc

Effectiveness of Vitamin C and Zinc as Adjuvant Therapy for Tuberculosis on MTB Culture Conversion

RAIT Study

A Pulmonary Tuberculosis Prediction Using CAD4TB Artificial Intelligence (Computer-Aided Detection for Tuberculosis) Based on Thoracic X-Ray Photos among Indonesian Subjects

UPCOMING PROJECTS

A Phase 3, Randomized, Open-label, Multicenter Trial to Evaluate the Efficacy, Safety, and Tolerability of 4-month and 6-month Quabodepistat-containing Regimens for Rifampicin-resistant/Multidrug-resistant Pulmonary Tuberculosis

PRISM-TB/RIGHT Foundation Grant

In-country Implementing Partner for PRISM-TB (Policy Reform Integrating STANDARD M10 for TB) Project.

QUANTUM Trial

Head Office Address

Jl. Balai Pustaka Barat 358E

Rawamangun, Pulo Gadung

Jakarta Timur, 13220

Any questions and inquiries, Feel free to contact us:

humas@yayasanrpri.org

Contact Us

Corresponding Address

Jalan Pegambiran No. 37 lantai 2,

Rawamangun, Pulo Gadung

Jakarta Timur, 13220